Occam Sciences Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Occam Sciences General Information

Description

Provider of therapeutic drug development services intended to offer bio-available forms of approved drugs. The company's services include developing drugs using green chemistry to design drugs that are bioavailable, enabling researchers to develop oral drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 33 Whitney Street
  • New Haven, CT 06510
  • United States
+1 (203) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Occam Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Jan-2016 00000 Completed Startup
1. Seed Round 21-Oct-2011 00000 00000 Completed Startup
To view Occam Sciences’s complete valuation and funding history, request access »

Occam Sciences Board Members (5)

Name Representing Role Since
Brian Dixon Occam Sciences Board Member 000 0000
David Whittaker MD Elm Street Ventures Board Member 000 0000
John Warner Occam Sciences Board Member 000 0000
Joseph Pont Occam Sciences Board Member 000 0000
Robert Bettigole Elm Street Ventures Board Member 000 0000
To view Occam Sciences’s complete board members history, request access »